Skip to main content

Advertisement

Table 1 Patients’ characteristics

From: Inhomogeneous myocardial stress perfusion in SPECT studies predicts future allograft dysfunction in heart transplant recipients

Variable All (n = 104) Homogeneous perfusion (n = 79) Inhomogeneous perfusion (n = 25) p value
Age at date of HTx (years) 49.4 ± 12.6 49.4 ± 12.6 49.4 ± 13.3 0.98
Gender (men/women) 86 (83 %)/18 (17 %) 65 (82 %)/14 (18 %) 21 (84 %)/4 (16 %) 0.46
BMI 25.8 ± 3.3 25.9 ± 3.5 25.3 ± 2.8 0.51
Reason for HTx     
 CAD 50 (48 %) 37 (47 %) 13 (52 %) 0.68
 Dilated cardiomyopathy 44 (42 %) 35 (44 %) 9 (36 %) 0.07
 Others 10 (10 %) 7 (9 %) 3 (12 %) 0.14
 Systemic hypertension 88 (85 %) 65 (82 %) 23 (92 %) 0.78
 Diabetes mellitus 18 (17 %) 14 (18 %) 4 (16 %) 0.68
 Hypercholesterolemia 76 (73 %) 58 (73 %) 18 (72 %) 0.25
 Renal failure 71 (68 %) 51 (65 %) 20 (80 %) 0.22
 Malignancy 14 (13 %) 13 (16 %) 1 (4 %) 0.12
 Peripheral artery disease 12 (12 %) 10 (13 %) 2 (8 %) 0.55
 Beta blockers 26 (25 %) 19 (24 %) 7 (28 %) 0.55
 Calcium channel antagonists 88 (85 %) 72 (91 %) 16 (64 %) 0.04
 ACE inhibitors 27 (26 %) 19 (24 %) 8 (32 %) 0.39
 Statins 94 (90 %) 73 (92 %) 21 (84 %) 0.77
 Coronary interventions in the follow-up 15 (15 %) 13 (16 %) 2 (8 %) 0.06
 MACE (incl. interventions) 20 (19 %) 15 (19 %) 5 (20 %) 0.14
 Deaths in observation period 11 (11 %) 7 (9 %) 4 (16 %) 0.26
  1. Values for age and BMI (body mass index) are expressed as mean ± standard deviation. All other data are absolute values